'Coronary revascularization' presentation slideshows

Appropriateness of Cardiac Care

Appropriateness of Cardiac Care. 4/11/2012 Paul Heidenreich, MD, MS Palo Alto VA. Relative Relationships. Served on American College of Cardiology (ACC) appropriateness rating panel for echocardiography Currently on writing committee for ACC ICD/CRT appropriateness criteria

875 views • 72 slides

Surgical Coronary Revascularization Who, What, When

1.35k views • 68 slides

Surgical Coronary Revascularization Who, What, When

709 views • 68 slides

Treatment Strategies for Women with Coronary Artery Disease

Treatment Strategies for Women with Coronary Artery Disease. Prepared for: Agency for Healthcare Research and Quality (AHRQ ). Accreditation Statement. Physician Credit Designation Statement

614 views • 41 slides

Proposed PMB guide to renal transplant listing

Proposed PMB guide to renal transplant listing. For SATS controversies meeting 7 May 2011. Background. Transplantation currently optimum available form of renal replacement therapy In ideal case Improved survival Improved QoL Cheaper Above not universally true for all on dialysis

501 views • 39 slides

PCI Revascularization Recommendations Pre-Procedural Considerations Procedural Considerations

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (and Coronary Revascularization). PCI Revascularization Recommendations Pre-Procedural Considerations Procedural Considerations Post-Procedural Considerations.

650 views • 38 slides

PreOperative Cardiac Clearance GME Chief Retreat September 2010 August 5th, 2009

PreOperative Cardiac Clearance GME Chief Retreat September 2010 August 5th, 2009. AGS. THE AMERICAN GERIATRICS SOCIETY Geriatrics Health Professionals. Leading change. Improving care for older adults. What is the appropriate cardiac evaluation?. Case #1

487 views • 37 slides

Surgical Intervention for Coronary Artery Diseases

Surgical Intervention for Coronary Artery Diseases. By Dr. Hanan Said Ali. Learning Objectives. Define coronary revascularization. Identify types of Coronary revascularization. Describe the following procedures: Percutaneous Transluminal Coronary Angioplasty and stent.

668 views • 31 slides

Rob Storey Senior Lecturer and Honorary Consultant in Cardiology, University of Sheffield, Sheffield UK

565 views • 30 slides

Case study

Case study. Mr. Wong is a 48-year old male, sales representative who travels often 170cm, 84kg , BMI 29 His brother just suffered from MI at age 40. Concerned about his health Want to do start exercise and lose weight. Evaluation. Classify client according to Risk Stratification Criteria

557 views • 28 slides

Complex Revascularization: Geographic Variations in Practice

Complex Revascularization: Geographic Variations in Practice. Case History and Presentation. Pre-intervention Angiograms. Appropriate Use Criteria: Variables Affecting Decision for Coronary Revascularization. Fractional Flow Reserve. European Guidelines on Myocardial Revascularization.

405 views • 26 slides

Observational Studies

Observational Studies . Effect of Antidiabetic Agent Choice on Cardiovascular Morbidity and Mortality in Type 2 Diabetes Mellitus Kate Gelperin, M.D., M.P.H. FDA CDER Office of Surveillance and Epidemiology Division of Drug Risk Evaluation (DDRE). Background. AUG 2006 submission from GSK

575 views • 24 slides

Is the Heart Team Approach Beneficial

Is the Heart Team Approach Beneficial. Dr. Gary P. Jones, MD, FACS LA CVT Institute, LLC. The Concept of Heart Team Becoming A More Interesting Concept. Team-Based Approach Already in Practice with . Oncology Organ Transplant Programs.

2.2k views • 23 slides

Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus

393 views • 22 slides

The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID)

The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID). The LIPID Study Group. N Engl J Med 1998;339:1349-57. LIPID - Background.

470 views • 19 slides

American Heart Association November 18, 2013 Dallas, Texas

Factors influencing treatment decisions for coronary artery disease after cardiac catheterization. American Heart Association November 18, 2013 Dallas, Texas. Brian R. Englum, MD, Phillip Schulte, PhD, Brian Gulack, MD, Manesh R. Patel, MD, John H. Alexander, MD, MHS, Peter K. Smith, MD.

386 views • 18 slides

219 views • 12 slides

Role of MSCT and MRI in High Risk Patients

Role of MSCT and MRI in High Risk Patients. Tadeusz Przew?ocki, Piotr Klimeczek, Mieczys?aw Pasowicz. Institute of Cardiology, Collegium Medicum Jagiellonian University John Paul II Hospital in Krakow. Risk of Cardiovascular Incidence. Multiple atherosclerosis risk factors

232 views • 10 slides

Randomized, double-blind active-control 10,462 high CV-risk hypertensive patients age 55+ yrs

Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH): Design. Randomized, double-blind active-control 10,462 high CV-risk hypertensive patients age 55+ yrs No history of symptomatic HF or evidence of LVEF<40%

147 views • 3 slides

Early statin therapy in patients with AMI Estimates of the rate of the primary endpoints

Early statin therapy in patients with AMI Estimates of the rate of the primary endpoints. Primary Endpoints : Composite of death , recurrent MI and coronary revascularization MACE adverse events : PCI. Cumulative incidence of MACE. Months after PCI.

115 views • 1 slides